| ACOXL |
Q9NUZ1
|
acyl-CoA oxidase like
|
Enzyme
|
5.2E-15 |
0.674 |
0.577 |
| APC |
P25054
|
APC regulator of WNT signaling pathway
|
|
1.00 |
0.373 |
0.962 |
| ATF1 |
P18846
|
activating transcription factor 1
|
|
0.63 |
0.588 |
0.577 |
| BRCA2 |
P51587
|
BRCA2 DNA repair associated
|
Nucleic acid binding
|
2.4E-25 |
0.379 |
0.846 |
| CASC8 |
|
cancer susceptibility 8
|
|
|
0.670 |
0.462 |
| CCAT2 |
|
colon cancer associated transcript 2
|
|
|
0.621 |
0.615 |
| CCND1 |
P24385
|
cyclin D1
|
Enzyme modulator
|
0.89 |
0.344 |
0.923 |
| CCND2 |
P30279
|
cyclin D2
|
Enzyme modulator
|
0.99 |
0.477 |
0.808 |
| CDH1 |
P12830
|
cadherin 1
|
|
0.15 |
0.401 |
0.808 |
| CDKN2B-AS1 |
|
CDKN2B antisense RNA 1
|
|
|
0.491 |
0.769 |
| COLCA1 |
Q6ZS62
|
colorectal cancer associated 1
|
|
|
0.780 |
0.154 |
| COLCA2 |
A8K830
|
colorectal cancer associated 2
|
|
0.75 |
0.769 |
0.154 |
| EDN1 |
P05305
|
endothelin 1
|
Signaling
|
0.46 |
0.380 |
0.846 |
| ERBB2 |
P04626
|
erb-b2 receptor tyrosine kinase 2
|
Kinase
|
6.0E-03 |
0.328 |
0.923 |
| ETV6 |
P41212
|
ETS variant transcription factor 6
|
Transcription factor
|
0.97 |
0.477 |
0.731 |
| FGFR2 |
P21802
|
fibroblast growth factor receptor 2
|
Kinase
|
1.00 |
0.380 |
0.808 |
| HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
| HLA-F |
P30511
|
major histocompatibility complex, class I, F
|
|
3.3E-05 |
0.631 |
0.654 |
| HNF1B |
P35680
|
HNF1 homeobox B
|
Nucleic acid binding
|
1.00 |
0.473 |
0.808 |
| LPAR1 |
Q92633
|
lysophosphatidic acid receptor 1
|
G-protein coupled receptor
|
0.19 |
0.534 |
0.808 |
| LRIG1 |
Q96JA1
|
leucine rich repeats and immunoglobulin like domains 1
|
Receptor
|
3.5E-02 |
0.601 |
0.538 |
| MMP2 |
P08253
|
matrix metallopeptidase 2
|
Enzyme
|
0.84 |
0.333 |
0.923 |
| NOS1 |
P29475
|
nitric oxide synthase 1
|
|
1.00 |
0.408 |
0.885 |
| PCAT1 |
|
prostate cancer associated transcript 1
|
|
|
0.575 |
0.615 |
| PIGU |
Q9H490
|
phosphatidylinositol glycan anchor biosynthesis class U
|
|
1.9E-05 |
0.670 |
0.462 |